These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38174756)

  • 21. [Progressive systemic scleroderma complicated by localized morphea].
    Konishi T; Yamao T; Wada J; Kusudo K; Fujita T
    Nihon Rinsho; 1974 Dec; 32(12):3613-9. PubMed ID: 4477212
    [No Abstract]   [Full Text] [Related]  

  • 22. Systemic sclerosis (scleroderma) and multiple sclerosis.
    Trostle DC; Helfrich D; Medsger TA
    Arthritis Rheum; 1986 Jan; 29(1):124-7. PubMed ID: 3947408
    [No Abstract]   [Full Text] [Related]  

  • 23. Emerging therapeutics in the management of connective tissue disease. Part II: Dermatomyositis and scleroderma.
    Kodumudi V; Bibb LA; Adalsteinsson JA; Shahriari N; Skudalski L; Santiago S; Grant-Kels JM; Lu J
    J Am Acad Dermatol; 2022 Jul; 87(1):21-38. PubMed ID: 35202777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Interstitial lung disease in systemic lupus erythematosus, progressive systemic sclerosis and dermatomyositis].
    Tokano Y; Hashimoto H; Hirose S
    Nihon Rinsho; 1990 Mar; 48(3):530-4. PubMed ID: 2355486
    [No Abstract]   [Full Text] [Related]  

  • 25. Systemic sclerosis, morphoea and breast cancer.
    Mittal G; Maddison P; Williams W
    Rheumatology (Oxford); 2006 Jan; 45(1):119-20. PubMed ID: 16091393
    [No Abstract]   [Full Text] [Related]  

  • 26. Palindromic morphea: multiple recurrence of morphea lesions in a case of systemic sclerosis.
    Mizutani H; Tanaka H; Okada H; Mizutani T; Shimizu M
    J Dermatol; 1992 May; 19(5):298-301. PubMed ID: 1644954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Collagen disease from the aspect of dermatology with special reference to overlapping of systemic lupus erythematosus, progressive sclerosis and dermatomyositis].
    Nishiyama S; Nishiwaki M; Ono K; Ushijima T
    Saishin Igaku; 1969 Oct; 24(10):2036-47. PubMed ID: 5349227
    [No Abstract]   [Full Text] [Related]  

  • 28. [Case of scleroderma with dermatomyositis].
    Fukushima H
    Naika; 1970; 25(5):825-30. PubMed ID: 5421838
    [No Abstract]   [Full Text] [Related]  

  • 29. Case of juvenile localized scleroderma with joint sclerosis and Sjögren's syndrome in a child with precocious puberty.
    Kim HS; Choi YJ; Park YM; Kim HO; Lee JY
    J Dermatol; 2011 Oct; 38(10):1024-7. PubMed ID: 21658114
    [No Abstract]   [Full Text] [Related]  

  • 30. Coexistence of recurrent generalized morphea and systemic sclerosis.
    Hayashi M; Ichiki Y; Kitajima Y
    Acta Derm Venereol; 2009; 89(3):329-30. PubMed ID: 19479146
    [No Abstract]   [Full Text] [Related]  

  • 31. Eosinophilic fasciitis (Shulman syndrome) in association with morphoea and systemic sclerosis.
    Coyle HE; Chapman RS
    Acta Derm Venereol; 1980; 60(2):181-82. PubMed ID: 6154917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of cancer among patients with systemic sclerosis.
    Rosenthal AK; McLaughlin JK; Gridley G; Nyrén O
    Cancer; 1995 Sep; 76(5):910-4. PubMed ID: 8625197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peristomal morphoea in a patient with systemic sclerosis.
    Jiang KW; Zagarella SS; Chan L; Harris A
    Australas J Dermatol; 2020 Nov; 61(4):e451-e452. PubMed ID: 32567671
    [No Abstract]   [Full Text] [Related]  

  • 34. [Sclerodermatomyositis and circumascribed scleroderma].
    Runne U; Fasshauer K
    Z Hautkr; 1977 Mar; 52(6):296-8. PubMed ID: 860539
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of calcinosis cutis in systemic sclerosis and dermatomyositis: A review of the literature.
    Traineau H; Aggarwal R; Monfort JB; Senet P; Oddis CV; Chizzolini C; Barbaud A; Francès C; Arnaud L; Chasset F
    J Am Acad Dermatol; 2020 Feb; 82(2):317-325. PubMed ID: 31302187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scleroderma renal crisis with minimal skin involvement and no serologic evidence of systemic sclerosis.
    Gonzalez EA; Schmulbach E; Bastani B
    Am J Kidney Dis; 1994 Feb; 23(2):317-9. PubMed ID: 8311093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ichthyotic-appearing skin changes associated with childhood morphea, systemic sclerosis, and systemic lupus erythematosus/scleroderma overlap.
    Williams CM; Storm CA; Burns C; Rigby W; Dinulos JG
    Pediatr Dermatol; 2010; 27(2):170-3. PubMed ID: 20537069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrent development of dermatomyositis and morphoea profunda.
    Park JH; Lee CW
    Clin Exp Dermatol; 2002 Jun; 27(4):324-7. PubMed ID: 12139684
    [No Abstract]   [Full Text] [Related]  

  • 39. [Case of a prolonged course of systemic scleroderma with elements of dermatomyositis].
    Mozhaĭtseva AG; Soboleva MS
    Sov Med; 1970 Sep; 33(9):146-7. PubMed ID: 5494164
    [No Abstract]   [Full Text] [Related]  

  • 40. [Scleroderma and dermatomyositis].
    Kondo H; Endo H
    Nihon Naika Gakkai Zasshi; 2005 May; 94(5):876-80. PubMed ID: 15926454
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.